Kythera

Did Allergan lose its $2.1B Kythera bet?

Over two years ago, Bernstein analyst Ronny Gal wrote that Allergan “obviously” has “much higher expectations than we do” for chin-fat drug Kybella.

Carly Helfand Nov 7, 2017 10:40am

Allergan shells out $2.5B for fat-freezing tech

Feb 13, 2017 11:52am

Allergan brand, rebates prime aesthetics biz for growth

Jun 30, 2016 11:45am